Enhanced proliferation of murine T cell lines following interaction of Poly(Glu60, Phe40) (GPhe) and antigen-presenting accessory cells. III. Possible mechanisms responsible for activity of GPhe.
The random copolymers (Glu80, Phe20)n (GPhe20), (Glu60, Phe40)n (GPhe), and (Glu50, Phe50)n (GPhe50) were compared for the capacity to augment proliferation of antigen-reactive murine T cell lines. GPhe20, GPhe, and GPhe50 showed "augmenting" activity in order of increasing potency. Phenylalanyl residues constituted a significant portion of the "active" determinant(s) in the GPhe polymers tested. High titer murine anti-GPhe (ascites fluid) inhibited augmentation by GPhe of exogenous (IL-1 + rat-conditioned media (RCM] driven T cell proliferation, indicating that (a) the antibodies by binding to specific active determinant(s) in GPhe may have prevented critical GPhe-APC membrane interaction, and/or (b) "GPhe-anti-GPhe" complexes interfered with necessary "processing" of GPhe by APCs. Time course studies demonstrated that the appearance of increased T cell proliferation after GPhe addition occurred after proliferation to (a) nominal antigen or (b) exogenous (IL-1 + RCM) had reached peak [3H]thymidine incorporation ([3HT]). This suggested that more than GPhe-APC membrane interaction was necessary for GPhe activity. Leupeptin, a lysosomal protease inhibitor, inhibited the augmentation of T cell proliferation by GPhe, which led to the conclusion that GPhe must be "processed" by APCs to exhibit activity.
Department of Pharmacology, Thomas Jefferson University, Philadelphia 19107.
D C
DC
Liu
J L
JL
Grun
P H
PH
Maurer
D000818:Animals; D000906:Antibodies; D000938:Antigen-Presenting Cells / Q000276:immunology*; D002455:Cell Division / Q000187:drug effects / Q000276:immunology; D002460:Cell Line; D002462:Cell Membrane / Q000378:metabolism; D003470:Culture Media; D000939:Epitopes / Q000276:immunology; D007375:Interleukin-1 / Q000502:physiology; D007976:Leupeptins / Q000494:pharmacology; D008213:Lymphocyte Activation / Q000187:drug effects; D051379:Mice; D010649:Phenylalanine / Q000031:analogs & derivatives* / Q000494:pharmacology; D011099:Polyglutamic Acid / Q000494:pharmacology*; D013601:T-Lymphocytes / Q000166:cytology* / Q000187:drug effects / Q000276:immunology; D013997:Time Factors
D000906:Antibodies; D003470:Culture Media; D000939:Epitopes; D007375:Interleukin-1; D007976:Leupeptins; D011099:Polyglutamic Acid; C023843:copolymer Glu(60)Phe(40); D010649:Phenylalanine; C032854:leupeptin